Go to content
UR Home

Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation

URN to cite this document:
DOI to cite this document:
Oury, Cécile ; Lubnow, Matthias ; Berger, Johannes ; Schneckenpointner, Roland ; Zeman, Florian ; Lunz, Dirk ; Philipp, Alois ; Foltan, Maik ; Lehle, Karla ; Heimerl, Susanne ; Hart, Christina ; Schmid, Christof ; Fisser, Christoph ; Müller, Thomas
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 26 Sep 2022 05:32


Objectives Unfractionated heparin (UFH) is the commonly used anticoagulant to prevent clotting of the ECMO circuit and thrombosis of the cannulated vessels. A side effect of UFH is heparin-induced thrombocytopenia (HIT). Little is known about HIT during ECMO and the impact of changing anticoagulation in ECMO patients with newly diagnosed HIT. The aim of the study was to determine the prevalence, ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons